My lab has been using the Agilent 50Mb SureSelect Human All Exon kit for many months now. Though the data is acceptable, we can’t help but wonder why our coverage plots look so different from Agilent coverage plots. (see attachment) Do other users produce data that results in coverage plots similar to those advertised by Agilent? If so, do you have any suggestions as to why we are seeing this disparity? Or, are our results the accepted norm?
Unconfigured Ad
Collapse
X
-
Your curves are consistent with what I see when running Agilent 50M SureSelect with paired 100bp reads.
Not sure what this "Agilent's data" curve you're showing is, but it may be due to any number of things--library prep, Agilent likely used paired 76bp reads (which they recommend), et cetera.Mendelian Disorder: A blogshare of random useful information for general public consumption. [Blog]
Breakway: A Program to Identify Structural Variations in Genomic Data [Website] [Forum Post]
Projects: U87MG whole genome sequence [Website] [Paper]
Comment
-
-
Thanks for the input.
Do you see similar coverage plots for Agilent mouse?
We have noticed that the curves for mouse differ greatly from human, using the same protocol, reagents and technicians. See attachment.Attached Files
Comment
-
-
I don't understand the Y-axis here. What are you calling "the exome"?
Haven't done Mouse myself. But again, I would not fret over this.
The Sureselect 50M performance is still high over its targets regardless.
Mendelian Disorder: A blogshare of random useful information for general public consumption. [Blog]
Breakway: A Program to Identify Structural Variations in Genomic Data [Website] [Forum Post]
Projects: U87MG whole genome sequence [Website] [Paper]
Comment
-
-
Script
Hi,Originally posted by SMO View PostMy lab has been using the Agilent 50Mb SureSelect Human All Exon kit for many months now. Though the data is acceptable, we can’t help but wonder why our coverage plots look so different from Agilent coverage plots. (see attachment) Do other users produce data that results in coverage plots similar to those advertised by Agilent? If so, do you have any suggestions as to why we are seeing this disparity? Or, are our results the accepted norm?
could you provide the script, with which you have generated the plot shown in "human coverage plot.pdf" ?
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 07-24-2026, 12:17 PM
|
0 responses
29 views
0 reactions
|
Last Post
by SEQadmin2
07-24-2026, 12:17 PM
|
||
|
Started by SEQadmin2, 07-23-2026, 11:41 AM
|
0 responses
21 views
0 reactions
|
Last Post
by SEQadmin2
07-23-2026, 11:41 AM
|
||
|
Started by SEQadmin2, 07-20-2026, 11:10 AM
|
0 responses
211 views
0 reactions
|
Last Post
by SEQadmin2
07-20-2026, 11:10 AM
|
||
|
Started by SEQadmin2, 07-13-2026, 10:26 AM
|
0 responses
78 views
0 reactions
|
Last Post
by SEQadmin2
07-13-2026, 10:26 AM
|
Comment